McElhaugh Michael J.
Director at ABUS
- Sold, on record
- $502k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Feb 4, 2025
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ABUSArbutus Biopharma CorpDirector
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ABUSPlan not statedJul 23, 2020 2020
Sold 20,000 shares at $5.01 ($100k)
McElhaugh Michael J., Chief Business Officer
Sold 1.4% of holdings ($7M position)1.4M shares leftFirst sale on recordFiling
- 2 Form 4 sale ABUSPlan not statedDec 14, 2020 +144 days
Sold 40,000 shares at $5.00 ($200k)
McElhaugh Michael J., Chief Business Officer
Sold 2.9% of holdings ($6.8M position)1.3M shares leftFiling
- 3 Form 4 sale ABUSPlan not statedFeb 9, 2021 +57 days
Sold 20,000 shares at $5.00 ($100k)
McElhaugh Michael J., Chief Business Officer
Sold 1.5% of holdings ($6.6M position)1.3M shares leftFiling
- 4 Form 4 sale ABUSRoutineFeb 2, 2024 +1088 days
Sold 10,164 shares at $2.31 ($23k)
McElhaugh Michael J., Interim President & CEO
10b5-1 planSold 0.7% of holdings ($3.5M position)1.5M shares leftFirst sale on recordFiling
- 5 Form 144 notice ABUSNoticeFeb 4, 2025 +368 days
Filed to sell 23,790 shares ($78k)
McElhaugh Michael J., Director and Officer
10b5-1 planFiling
- 6 Form 4 sale ABUSRoutineFeb 4, 2025 same day
Sold 23,790 shares at $3.28 ($78k)
McElhaugh Michael J., Interim President & CEO
10b5-1 planSold 1.6% of holdings ($4.9M position)1.5M shares leftFollows a Form 144Filing
- 7 Form 144 notice ABUSNoticeApr 15, 2025 +70 days
Filed to sell 53,114 shares ($170k)
McElhaugh Michael J., Director
No 10b5-1 planFiling
- 8 Form 144 notice ABUSNoticeApr 21, 2025 +6 days
Filed to sell 246,886 shares ($805k)
McElhaugh Michael J., Director
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | Apr 21, 2025 | ABUS | Director | Form 144 notice | 246,886 | $805k | Notice | SEC | |
| Apr 15, 2025 | Apr 15, 2025 | ABUS | Director | Form 144 notice | 53,114 | $170k | Notice | SEC | |
| Feb 4, 2025 | Feb 5, 2025 | ABUS | Interim President & CEO | Form 4 sale | 23,790 | $78k | 1.6% | Routine | SEC |
| Feb 4, 2025 | Feb 4, 2025 | ABUS | Director and Officer | Form 144 notice | 23,790 | $78k | Notice | SEC | |
| Feb 2, 2024 | Feb 5, 2024 | ABUS | Interim President & CEO | Form 4 sale | 10,164 | $23k | 0.7% | Routine | SEC |
| Feb 9, 2021 | Feb 10, 2021 | ABUS | Chief Business Officer | Form 4 sale | 20,000 | $100k | 1.5% | Plan not stated | SEC |
| Dec 14, 2020 | Dec 16, 2020 | ABUS | Chief Business Officer | Form 4 sale | 40,000 | $200k | 2.9% | Plan not stated | SEC |
| Jul 23, 2020 | Jul 27, 2020 | ABUS | Chief Business Officer | Form 4 sale | 20,000 | $100k | 1.4% | Plan not stated | SEC |